Crosignani A - Search Results

1

Spontaneous hypoglycemia in patients with cystic fibrosis.

Battezzati A, Battezzati PM, Costantini D, Seia M, Zazzeron L, Russo MC, Daccò V, Bertoli S, Crosignani A, Colombo C. Battezzati A, et al. Among authors: crosignani a. Eur J Endocrinol. 2007 Mar;156(3):369-76. doi: 10.1530/eje.1.02344. Eur J Endocrinol. 2007. PMID: 17322497

2

Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome.

Colombo C, Battezzati PM, Crosignani A, Morabito A, Costantini D, Padoan R, Giunta A. Colombo C, et al. Among authors: crosignani a. Hepatology. 2002 Dec;36(6):1374-82. doi: 10.1053/jhep.2002.37136. Hepatology. 2002. PMID: 12447862

3

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, Zimmer-Nechemias L, Setchell KD. Colombo C, et al. Among authors: crosignani a. Hepatology. 1992 Oct;16(4):924-30. doi: 10.1002/hep.1840160412. Hepatology. 1992. PMID: 1398498 Clinical Trial.

4

Effects of taurine and ursodeoxycholic acid on liver function tests in patients with cystic fibrosis.

Colombo C, Battezzati PM, Crosignani A, Assaisso M, Ronchi M, Giunta A. Colombo C, et al. Among authors: crosignani a. Acta Univ Carol Med (Praha). 1990;36(1-4):148-51. Acta Univ Carol Med (Praha). 1990. PMID: 2130679

5

Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease.

Colombo C, Crosignani A, Battezzati PM, Castellani MR, Comi S, Melzi ML, Giunta A. Colombo C, et al. Among authors: crosignani a. J Hepatol. 1999 Oct;31(4):672-7. doi: 10.1016/s0168-8278(99)80347-x. J Hepatol. 1999. PMID: 10551391

6

Liver involvement in cystic fibrosis.

Colombo C, Crosignani A, Battezzati PM. Colombo C, et al. Among authors: crosignani a. J Hepatol. 1999 Nov;31(5):946-54. doi: 10.1016/s0168-8278(99)80299-2. J Hepatol. 1999. PMID: 10580595 Review. No abstract available.

7

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.

Colombo C, Setchell KD, Podda M, Crosignani A, Roda A, Curcio L, Ronchi M, Giunta A. Colombo C, et al. Among authors: crosignani a. J Pediatr. 1990 Sep;117(3):482-9. doi: 10.1016/s0022-3476(05)81103-5. J Pediatr. 1990. PMID: 2391610

8

Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.

Colombo C, Crosignani A, Alicandro G, Zhang W, Biffi A, Motta V, Corti F, Setchell KDR. Colombo C, et al. Among authors: crosignani a. J Pediatr. 2016 Oct;177:59-65.e1. doi: 10.1016/j.jpeds.2016.05.008. Epub 2016 Jun 11. J Pediatr. 2016. PMID: 27297203

9

Complement system is not activated in primary biliary cirrhosis.

Gardinali M, Conciato L, Cafaro C, Crosignani A, Battezzati PM, Agostoni A, Podda M. Gardinali M, et al. Among authors: crosignani a. Clin Immunol Immunopathol. 1998 Jun;87(3):297-303. doi: 10.1006/clin.1998.4542. Clin Immunol Immunopathol. 1998. PMID: 9646840

10

ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.

Degiorgio D, Crosignani A, Colombo C, Bordo D, Zuin M, Vassallo E, Syrén ML, Coviello DA, Battezzati PM. Degiorgio D, et al. Among authors: crosignani a. J Gastroenterol. 2016 Mar;51(3):271-80. doi: 10.1007/s00535-015-1110-z. Epub 2015 Sep 1. J Gastroenterol. 2016. PMID: 26324191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters